Pantoprazol Sandoz (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Sandoz, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Sandoz is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Erosive esophagitis: heals erosions caused by chronic acid exposure. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens (as adjunct): enhances ulcer healing when combined with antibiotics.

Pantoprazol Sandoz is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Abdominal pain or discomfort. - Nausea or vomiting. - Flatulence or bloating. - Constipation.

Serious or Rare Side Effects: - Acute interstitial nephritis: inflammation of kidney tissue. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Clostridioides difficile‑associated diarrhea: persistent watery stools. - Low magnesium levels (hypomagnesemia): may cause muscle cramps or arrhythmia. - Fracture risk with long‑term use: decreased bone mineral density. - Liver enzyme elevations: indicating potential hepatic stress.

When prescribing Pantoprazol Sandoz, consider the following safety measures: - Assess renal function: adjust use in severe kidney impairment. - Review bone health: monitor patients on long‑term therapy for osteoporosis risk. - Evaluate electrolyte status: watch for hypomagnesemia during prolonged treatment. - Consider infection risk: prolonged acid suppression may increase susceptibility to gastrointestinal infections. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Pantoprazol Sandoz may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir or nelfinavir: decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet activity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Methotrexate: possible accumulation with high‑dose regimens. - Digoxin: altered serum concentrations. - Iron supplements: decreased iron absorption when taken simultaneously.